|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01255 TATA HEALTH
Nominal 
2.100 0.000 (0.000%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 47,275 | -4.543% | 99,799 | 124,455 | 207,542 | 144,606 |
| Cost of Sales | (16,306) | 123.830% | (19,535) | (39,507) | (56,780) | (30,662) |
| Gross Profit | 30,969 | -26.683% | 80,264 | 84,948 | 150,762 | 113,944 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (4,001) | (26,726) | (11,259) | (1,452) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (210) | (400) | |
| Profit / (Loss) before Taxation | (1,110) | -- | 13,987 | (68,031) | (35,420) | 2,497 | |
| Taxation | 0 | -- | (637) | (307) | (626) | (898) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 820 | -- | 0 | 0 | 3,752 | 6,448 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (290) | -- | 13,350 | (68,338) | (32,294) | 8,047 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 548 | -58.859% | 2,505 | 1,326 | (722) | 1,049 |
| Depreciation & Amortisation | 4,272 | -18.224% | 11,550 | 15,539 | 14,158 | 12,017 |
| Directors' Emoluments | -- | -- | 8,898 | 9,372 | 10,241 | 8,624 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Disclaimer | Disclaimer | Disclaimer | Unqualified (Modified Report) |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -0.100 | -- | 5.000 | -28.000 | -13.000 | 3.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.070) | 0.005 | 0.156 | 0.054 |
| NBV per share ($) | (0.227) | -- | (0.224) | (0.265) | 0.007 | 0.132 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -290 |
| %Change | -- |
| EPS / (LPS) | HKD -0.001 |
| NBV Per Share ($) | HKD -0.227 |